Advanced search
Publication Cover
Clinical Lipidology Volume 5, 2010 - Issue 6
Submit an article Journal homepage
369
Views
22
CrossRef citations to date
0
Altmetric
Reviews

Reducing residual vascular risk in patients with atherogenic dyslipidemia: where do we go from here?

Michel P HermansEndocrinology & Nutrition, Cliniques universitaires St-Luc, Brussels, BelgiumCorrespondence[email protected]
&
Jean-Charles FruchartFondation Coeur & Artères, Lille, France
Pages 811-826 | Published online: 18 Jan 2017

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Richard Kones. (2011) Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey. Drug Design, Development and Therapy 5, pages 325-380.
Read now

Articles from other publishers (21)

Arturo J Martí-Carvajal, Juan Bautista De Sanctis, Ricardo Hidalgo, Cristina Elena Martí-Amarista, Eduardo Alegría, Andrea Correa-Pérez, Diana Monge Martín & Ricardo J Riera Lizardo. (2022) Colchicine for the primary prevention of cardiovascular events. Cochrane Database of Systematic Reviews 2022:6.
Crossref
Yi-Ting Huang, Li-Ting Ho, Hsin-Yin Hsu, Yu-Kang Tu & Kuo-Liong Chien. (2022) Efficacy and Safety of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors as Adjuvant Treatments for Patients with Hypercholesterolemia Treated with Statin: A Systematic Review and Network Meta-analysis. Frontiers in Pharmacology 13.
Crossref
Hagos Amare Gebreyesus, Girmatsion Fisseha Abreha, Sintayehu Degu Besherae, Merhawit Atsbha Abera, Abraha Hailu Weldegerima, Aregawi Haileslassie Gidey, Afework Mulugeta Bezabih, Tefera Belachew Lemma & Tsinuel Girma Nigatu. (2022) High atherogenic risk concomitant with elevated HbA1c among persons with type 2 diabetes mellitus in North Ethiopia. PLOS ONE 17:2, pages e0262610.
Crossref
T. Vromen, R. W. M. Brouwers, H. T. Jorstad, R. A. Kraaijenhagen, R. F. Spee, M. E. Wittekoek, M. J. Cramer, J. M. C. van Hal, L. Hofstra, P. M. J. C. Kuijpers, E. C. de Melker, S. F. Rodrigo, M. Sunamura, N. H. M. K. Uszko-Lencer & H. M. Kemps. (2021) Novel advances in cardiac rehabilitation. Netherlands Heart Journal 29:10, pages 479-485.
Crossref
Abdolkarim Mahrooz, Yasaman Shokri, Atena Variji, Mehryar Zargari, Ahad Alizadeh & Ehsan Mehtarian. (2021) Improved risk assessment of coronary artery disease by substituting paraoxonase 1 activity for HDL-C: Novel cardiometabolic biomarkers based on HDL functionality. Nutrition, Metabolism and Cardiovascular Diseases 31:4, pages 1166-1176.
Crossref
Michel P. Hermans & Paul Valensi. (2018) Elevated triglycerides and low high-density lipoprotein cholesterol level as marker of very high risk in type 2 diabetes. Current Opinion in Endocrinology & Diabetes and Obesity 25:2, pages 118-129.
Crossref
Juan Gabriel Juárez-Rojas, Rosalinda Posadas-Sánchez, María del Rocío Martínez-Alvarado, Margarita Torres-Tamayo, Esteban Jorge-Galarza, Erika Yamel Mancilla-Valenzuela, Carlos Posadas-Romero, Guillermo Celestino Cardoso-Saldaña, María del Carmen González-Salazar, Gilberto Vargas-Alarcón & Aida Xochitl Medina-Urrutia. (2017) Association of Adiponectin with Subclinical Atherosclerosis in a Mexican-Mestizo Population. Archives of Medical Research 48:1, pages 73-78.
Crossref
Michel P. Hermans, Sylvie A. Ahn & Michel F. Rousseau. (2014) Parental brevity linked to cardiometabolic risk in diabetic descendants. Journal of Diabetes and its Complications 28:2, pages 141-146.
Crossref
Michel P Hermans, Sylvie A Ahn & Michel F Rousseau. (2014) Novel unbiased equations to calculate triglyceride-rich lipoprotein cholesterol from routine non-fasting lipids. Cardiovascular Diabetology 13:1, pages 56.
Crossref
Giulia Rastrelli, Giovanni Corona, Francesco Lotti, Antonio Aversa, Marco Bartolini, Mario Mancini, Edoardo Mannucci & Mario Maggi. (2014) Flaccid Penile Acceleration as a Marker of Cardiovascular Risk in Men without Classical Risk Factors. The Journal of Sexual Medicine 11:1, pages 173-186.
Crossref
Michel P. Hermans, Sylvie A. Ahn, Yovan P. Mahadeb & Michel F. Rousseau. (2013) Sleep apnoea syndrome and 10-year cardiovascular risk in females with type 2 diabetes: relationship with insulin secretion and insulin resistance. Diabetes/Metabolism Research and Reviews 29:3, pages 227-234.
Crossref
Michel P Hermans, Sylvie A Ahn & Michel F Rousseau. (2013) Discriminant ratio and biometrical equivalence of measured vs. calculated apolipoprotein B100 in patients with T2DM. Cardiovascular Diabetology 12:1, pages 39.
Crossref
Filipa Mascarenhas-Melo, Filipe Palavra, Daniela Marado, José Sereno, Edite Teixeira-Lemos, Isabel Freitas, Maria Isabel-Mendonça, Rui Pinto, Frederico Teixeira & Flávio Reis. (2013) Emergent Biomarkers of Residual Cardiovascular Risk in Patients with Low HDL-c and/or High Triglycerides and Average LDL-c Concentrations: Focus on HDL Subpopulations, Oxidized LDL, Adiponectin, and Uric Acid. The Scientific World Journal 2013, pages 1-16.
Crossref
Michel P Hermans, Sylvie A Ahn & Michel F Rousseau. (2012) The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females. Lipids in Health and Disease 11:1.
Crossref
Laurent Querton, Martin Buysschaert & Michel P. Hermans. (2012) Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels. Journal of Clinical Lipidology 6:5, pages 434-442.
Crossref
Michel P. Hermans, Sylvie A. Ahn & Michel F. Rousseau. (2012) eNOS [Glu298Asp] polymorphism, erectile function and ocular pressure in type 2 diabetes. European Journal of Clinical Investigation 42:7, pages 729-737.
Crossref
Michel P. Hermans, Sylvie A. Ahn & Michel F. Rousseau. (2012) The multi-faceted outcomes of conjunct diabetes and cardiovascular familial history in type 2 diabetes. Journal of Diabetes and its Complications 26:3, pages 187-194.
Crossref
Alberto Zambon. (2011) Residual cardiovascular risk in secondary prevention. Internal and Emergency Medicine 6:S1, pages 61-68.
Crossref
Diego Vanuzzo. (2011) The epidemiological concept of residual risk. Internal and Emergency Medicine 6:S1, pages 45-51.
Crossref
Michel P. Hermans & Jean-Charles Fruchart. (2011) Reducing vascular events risk in patients with dyslipidaemia: an update for clinicians. Therapeutic Advances in Chronic Disease 2:5, pages 307-323.
Crossref
Michel P Hermans, Frank M Sacks, Sylvie A Ahn & Michel F Rousseau. (2011) Non-HDL-cholesterol as valid surrogate to apolipoprotein B100 measurement in diabetes: Discriminant Ratio and unbiased equivalence. Cardiovascular Diabetology 10:1, pages 20.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.